Healthcare - Biotechnology - NASDAQ - US
$ 1.04
0.971 %
$ 57.2 M
Market Cap
-0.59
P/E
INCOME STATEMENT
0
REVENUE
-132 M
OPERATING INCOME
-122 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Prelude Therapeutics Incorporated
| Revenue | 0 |
| Cost Of Revenue | 1.17 M |
| Gross Profit | -1.17 M |
| Operating Expenses | 132 M |
| Operating Income | -132 M |
| Other Expenses | -10.4 M |
| Net Income | -122 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 1.2 | 3.0 | 2.2 | 0.5 | 0.4 | 0.1 |
| Gross Profit | (1.2) | (3.0) | (2.2) | (0.5) | (0.4) | (0.1) |
| OPERATING INCOME | ||||||
| Operating Expenses | 132.3 | 123.5 | 113.7 | 58.8 | 28.1 | 15.0 |
| Selling, General and Administrative Expenses | 28.9 | 30.7 | 27.0 | 10.6 | 3.8 | 2.4 |
| Research and Development Expenses | 103.4 | 92.9 | 86.8 | 48.2 | 24.3 | 12.6 |
| Operating Income | (132.3) | (123.5) | (113.7) | (58.8) | (28.1) | (15.0) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | (1.3) | 0 | 0 | 0 | 0 |
| Total Other Income | 10.4 | 8.1 | 2.0 | 1.8 | 0.5 | 0.3 |
| Pre-Tax Income | (121.8) | (115.4) | (111.7) | (56.9) | (27.6) | (14.7) |
| NET INCOME | ||||||
| Tax Provision | 0 | (8.1) | (0.9) | 0.3 | 0.2 | 0.3 |
| Net Income | (121.8) | (107.3) | (110.8) | (56.9) | (27.6) | (14.7) |
| EPS | 2.02 | 2.27 | 2.33 | 1.3 | 0.85 | 0.46 |